AlphaFold predicted structure
FOXF2 · Q12947

Mean pLDDT
56.4/ 100
Low
444 residues
Confidence breakdown
- Very high(≥ 90)16%
- Confident(70–90)7%
- Low(50–70)19%
- Very low(< 50)59%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
forkhead box F2
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Monogenic hearing loss
BIALLELIC, autosomal or pseudoautosomalFamilial cerebral small vessel disease
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownstroke disorder
ischemic stroke
cerebral artery occlusion
cerebral arterial disease
response to anti-thyroid drug
Drug-induced agranulocytosis
Transient global amnesia
cerebrovascular disorder
small vessel stroke
vertebral column disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Forkhead box protein F2
Probable transcription activator for a number of lung-specific genes (PubMed:8626802). Mediates up-regulation of the E3 ligase IRF2BPL and drives ubiquitination and degradation of CTNNB1 (PubMed:29374064)
FOXF2 · Q12947

Mean pLDDT
56.4/ 100
Low
444 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0